Scientific Human Clinical Study Confirms kollaGen II-xs™ Efficacy For Joint & Connective Tissue Disorders!

Posted by:

Murrieta, California – September 9, 2013 – Certified Nutraceuticals, Inc. is pleased to announce the positive initial results of the ongoing Human Clinical Studies for the efficacy of kollaGenII-xs™ U.S. Patent #8,344,106 B1-Avian Sternum Collagen Type II powder Hydrolysate. This is the natural blend of Mucopolysaccharide compounds and amino acids which basically are the building blocks of joint cartilage. The process preserves all important nutrients and capable amino acids in order for kollaGenII-xs™ to be effective after ...

Continue Reading →